Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer-Reference-Cited by-同舟云学术

Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer

Published:2016-12-21 Issue:9 Volume:123 Page:1635-1642
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Dess Robert T.¹^ORCID,Jackson William C.¹,Suy Simeng²,Soni Payal D.¹,Lee Jae Y.¹,Abugharib Ahmed E.³,Zumsteg Zachary S.⁴,Feng Felix Y.⁵,Hamstra Daniel A.⁶,Collins Sean P.²,Spratt Daniel E.¹

Affiliation:

1. Department of Radiation Oncology; University of Michigan; Ann Arbor Michigan

2. Department of Radiation Oncology; Georgetown University; Washington District of Columbia

3. Department of Oncology; Sohag University; Sohag Egypt

4. Department of Radiation Oncology; Cedars-Sinai Medical Center; Los Angeles California

5. Department of Radiation Oncology; University of California-San Francisco; San Francisco California

6. Department of Radiation Oncology; Texas Oncology; Irving Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer;King;Int J Radiat Oncol Biol Phys.,2012

2. Virtual HDR CyberKnife SBRT for localized prostatic carcinoma: 5-year disease-free survival and toxicity observations [serial online];Fuller;Front Oncol.,2014

3. Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a 6 year study [serial online];Katz;Radiat Oncol.,2014

4. Stereotactic body radiation therapy for low and intermediate risk prostate cancer-results from a multi-institutional clinical trial;Hannan;Eur J Cancer.,2016

5. Institute of Clinical Research-Clinical Trials and Statistics Unit, Division of Clinical Studies The Prostate Advances in Comparative Evidence (PACE) Study: International randomised study of laparoscopic prostatectomy vs stereotactic body radiotherapy (SBRT) and conventionally fractionated radiotherapy vs SBRT for early stage organ-confined prostate cancer http://www.isrctn.com/ISRCTN17627211 2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for the long‐term persistent genitourinary toxicity after stereotactic body radiation therapy for localized prostate cancer: A single‐center, retrospective study of 306 patients;International Journal of Urology;2024-06

2. Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients;Current Oncology;2023-05-16

3. Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating 2 Ultrahypofractionated Regimens for Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2022-12

4. Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided radiotherapy;Radiotherapy and Oncology;2022-06

5. Quality of Life After Prostate Cancer Treatment;International Journal of Radiation Oncology*Biology*Physics;2021-07